Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 200 Total
GNLX - Genelux Corp - Stock Price Chart
TickerGNLX [NASD, RUT]
CompanyGenelux Corp
CountryUSA
IndustryBiotechnology
Market Cap135.54MEPS (ttm)-0.97
P/E-EPS this Y20.91%
Forward P/E-EPS next Y-29.34%
PEG-EPS past 5Y-23.84%
P/S13554.00EPS next 5Y-
P/B8.98EPS Q/Q30.73%
Dividend-Sales Q/Q-95.29%
Insider Own25.33%Inst Own22.36%
Insider Trans-4.71%Inst Trans-
Short Float11.52%EarningsMay 09/a
Analyst Recom1.00Target Price26.00
Avg Volume128.97K52W Range3.06 - 40.98
May-09-24 11:53PM GNLX Stock Earnings: Genelux Misses EPS for Q1 2024 (InvestorPlace) +6.07%
04:25PM Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates (GlobeNewswire)
Apr-26-24 09:35AM Down -48.37% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround (Zacks)
Apr-23-24 09:35AM Down -45.44% in 4 Weeks, Here's Why Genelux Corporation (GNLX) Looks Ripe for a Turnaround (Zacks)
Apr-05-24 09:35AM After Plunging -26.21% in 4 Weeks, Here's Why the Trend Might Reverse for Genelux Corporation (GNLX) (Zacks)
Apr-04-24 12:00PM All You Need to Know About Genelux Corporation (GNLX) Rating Upgrade to Buy (Zacks)
Apr-02-24 07:52AM GNLX Stock Earnings: Genelux Misses EPS for Q4 2023 (InvestorPlace)
Apr-01-24 07:00AM Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire) -18.51%
Dec-15-23 03:01PM Insider Sell Alert: Director James Tyree Offloads 9,000 Shares of Genelux Corp (GNLX) (GuruFocus.com) -13.23%
Nov-27-23 07:00AM Genelux Corporation Receives FDA Fast Track Designation for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer (GlobeNewswire)
ACXP - Acurx Pharmaceuticals Inc - Stock Price Chart
TickerACXP [NASD]
CompanyAcurx Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap44.19MEPS (ttm)-1.19
P/E-EPS this Y31.74%
Forward P/E-EPS next Y-46.50%
PEG-EPS past 5Y-17.77%
P/S-EPS next 5Y-
P/B7.33EPS Q/Q-13.47%
Dividend-Sales Q/Q-
Insider Own15.26%Inst Own7.88%
Insider Trans0.00%Inst Trans129.36%
Short Float4.58%EarningsMay 15/b
Analyst Recom1.00Target Price11.00
Avg Volume75.75K52W Range1.17 - 8.82
May-16-24 03:00AM Acurx Pharmaceuticals Inc (ACXP) Q1 2024 Earnings Call Transcript Highlights: Key Financial and ... (GuruFocus.com)
May-15-24 10:40PM Q1 2024 Acurx Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) +7.66%
09:53AM ACXP Stock Earnings: Acurx Pharmaceuticals Misses EPS for Q1 2024 (InvestorPlace)
09:00AM Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection (PR Newswire)
07:00AM Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update (PR Newswire)
May-02-24 07:00AM Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference (PR Newswire)
Apr-25-24 10:12AM Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference (PR Newswire)
Apr-23-24 10:57AM Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update (PR Newswire)
Mar-21-24 03:01AM Acurx Pharmaceuticals, Inc. Announces Participation in the LD Micro Invitational XIV (Newsfile)
Mar-19-24 09:32AM Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript (Insider Monkey) -18.53%
SISI - Shineco Inc - Stock Price Chart
TickerSISI [NASD]
CompanyShineco Inc
CountryChina
IndustryFarm Products
Market Cap7.87MEPS (ttm)-1.09
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S3.97EPS next 5Y-
P/B0.22EPS Q/Q-235.82%
Dividend-Sales Q/Q150.23%
Insider Own2.64%Inst Own0.87%
Insider Trans0.00%Inst Trans3.32%
Short Float0.48%Earnings-
Analyst Recom-Target Price-
Avg Volume264.45K52W Range0.61 - 6.93
May-20-24 11:53AM SISI Stock Earnings: Shineco Reported Results for Q3 2024 (InvestorPlace) +9.38%
07:36AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
May-01-24 05:14AM Shineco Develops Revolutionary New Product with Varied Applications to Positively Impact the Health Care Industry (PR Newswire) +5.36%
Mar-12-24 04:30PM Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Feb-14-24 07:00AM Shineco Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement (GlobeNewswire) -5.11%
Nov-17-23 09:00AM Shineco Announces the Appointment of Two New Executive Officers (GlobeNewswire) -8.00%
Oct-30-23 09:00AM Shineco Opens Healthy Food Restaurant with Focus on Advanced Nutrition (GlobeNewswire) -6.20%
Oct-04-23 09:00AM Shineco to Increase R&D to Explore New High-Tech Medical Product Applications (GlobeNewswire) +7.14%
Jul-10-23 09:00AM Shineco Subsidiary Receives Marketing Approval from Chinas Regulatory Body for its Cardiac 5-Minute Test (GlobeNewswire) +6.97%
Jun-28-23 09:00AM Shineco Enters into Cooperation Agreement with Kangling Medical to Develop New Medical Products Company (GlobeNewswire)
GLUE - Monte Rosa Therapeutics Inc - Stock Price Chart
TickerGLUE [NASD, RUT]
CompanyMonte Rosa Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap216.94MEPS (ttm)-2.53
P/E-EPS this Y18.06%
Forward P/E-EPS next Y5.35%
PEG-EPS past 5Y-96.71%
P/S204.66EPS next 5Y-
P/B1.41EPS Q/Q18.15%
Dividend-Sales Q/Q-
Insider Own36.88%Inst Own63.82%
Insider Trans0.00%Inst Trans1.00%
Short Float6.00%EarningsMay 09/b
Analyst Recom1.00Target Price15.00
Avg Volume158.70K52W Range2.44 - 8.84
Today 07:00AM Monte Rosa Therapeutics Presents Preclinical Data at Digestive Disease Week 2024 Highlighting Therapeutic Potential of MRT-6160 in Inflammatory Bowel Disease (GlobeNewswire) -13.23%
May-16-24 01:09PM Monte Rosa Therapeutics Prices $100 Million Public Offering (MT Newswires)
07:00AM Monte Rosa Therapeutics Announces Pricing of $100 Million Underwritten Public Offering (GlobeNewswire)
May-15-24 04:01PM Monte Rosa Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
May-10-24 03:26PM Monte Rosa Therapeutics Reports Q1 2024 Financial Results: A Detailed Overview (GuruFocus.com) -6.37%
May-09-24 01:55PM GLUE Stock Earnings: Monte Rosa Therapeutics Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
07:21AM Monte Rosa Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
May-02-24 04:01PM Monte Rosa Therapeutics Announces the Departure of Owen Wallace, Ph.D., Chief Scientific Officer (GlobeNewswire) -5.72%
Apr-29-24 10:36AM UBS Adjusts Monte Rosa Therapeutics Price Target to $20 From $22, Maintains Buy Rating (MT Newswires) +5.25%
ZENV - Zenvia Inc - Stock Price Chart
TickerZENV [NASD]
CompanyZenvia Inc
CountryBrazil
IndustrySoftware - Application
Market Cap138.20MEPS (ttm)-0.29
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.85EPS next 5Y-
P/B0.75EPS Q/Q79.63%
Dividend-Sales Q/Q31.60%
Insider Own97.28%Inst Own9.21%
Insider Trans0.00%Inst Trans-4.38%
Short Float5.67%EarningsApr 30/a
Analyst Recom3.00Target Price1.80
Avg Volume76.77K52W Range0.65 - 3.88
Today 07:49AM Top Premarket Decliners (MT Newswires) -14.29%
07:39AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
May-15-24 01:53PM ZENV Stock Earnings: Zenvia Reported Results for Q4 2023 (InvestorPlace)
07:00AM Zenvia Files its Annual Report on Form 20-F for Fiscal Year 2023 (PR Newswire)
May-13-24 08:30PM ZENVIA Reports Q4 2023 and FY 2023 Results (PR Newswire)
May-03-24 07:00AM 3 Little-Known Stocks That Could Make You Rich by 2029 (InvestorPlace)
Apr-20-24 06:00AM Hidden Titans: 3 Stocks Ready to Outperform in the Next Earnings Season (InvestorPlace)
Apr-15-24 08:50AM ZENVIA sets agenda for fiscal fourth quarter and full year results (PR Newswire)
Apr-09-24 08:00AM Secret Millionaires: 3 Underpriced Stocks to Skyrocket Your Wealth (InvestorPlace)
Apr-04-24 08:38AM Millionaire Blueprint: 3 Game-Changing Stocks You Cant Ignore (InvestorPlace)
RVPH - Reviva Pharmaceuticals Holdings Inc. - Stock Price Chart
TickerRVPH [NASD]
CompanyReviva Pharmaceuticals Holdings Inc.
CountryUSA
IndustryBiotechnology
Market Cap36.44MEPS (ttm)-1.59
P/E-EPS this Y25.94%
Forward P/E-EPS next Y-2.78%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q17.76%
Dividend-Sales Q/Q-
Insider Own17.71%Inst Own20.08%
Insider Trans0.00%Inst Trans-42.95%
Short Float5.44%EarningsMay 14/b
Analyst Recom1.00Target Price15.00
Avg Volume281.01K52W Range1.46 - 8.00
Today 08:00AM Reviva to Participate in the BIO International Convention (GlobeNewswire) -15.26%
May-15-24 08:00AM Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia (GlobeNewswire) -6.30%
May-14-24 01:53PM RVPH Stock Earnings: Reviva Pharmaceuticals Beats EPS for Q1 2024 (InvestorPlace) +7.35%
08:00AM Reviva Reports First Quarter 2024 Financial Results and Recent Business Highlights (GlobeNewswire)
May-13-24 08:00AM Reviva to Present New Preclinical Efficacy Data on Brilaroxazine in Idiopathic Pulmonary Fibrosis at 2024 ATS International Conference (GlobeNewswire) -9.09%
May-09-24 08:00AM Reviva to Present New Non-Clinical Pharmacology Data on Brilaroxazine at the ASPET 2024 Annual Meeting (GlobeNewswire) -24.11%
Apr-15-24 08:30AM Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia (GlobeNewswire) -5.69%
08:05AM Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights (GlobeNewswire)
Mar-28-24 08:00AM Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the SIRS 2024 Annual Meeting (GlobeNewswire)
Mar-26-24 08:00AM Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the ASCPT 2024 Annual Meeting (GlobeNewswire) +21.97%
RENT - Rent the Runway Inc - Stock Price Chart
TickerRENT [NASD, RUT]
CompanyRent the Runway Inc
CountryUSA
IndustryApparel Retail
Market Cap116.30MEPS (ttm)-16.97
P/E-EPS this Y39.39%
Forward P/E-EPS next Y2.94%
PEG-EPS past 5Y8.41%
P/S0.39EPS next 5Y-
P/B-EPS Q/Q12.92%
Dividend-Sales Q/Q0.53%
Insider Own57.55%Inst Own22.63%
Insider Trans-27.91%Inst Trans-73.19%
Short Float26.06%EarningsJun 06/a
Analyst Recom1.67Target Price20.50
Avg Volume1.43M52W Range4.46 - 58.00
May-17-24 11:32AM Why Is Rent the Runway (RENT) Stock Up 15% Today? (InvestorPlace) +13.89%
May-16-24 04:01PM Rent the Runway to Report First Quarter 2024 Results on June 6, 2024 (GlobeNewswire) +18.14%
May-14-24 01:48PM 3 Short-Squeeze Stocks Ready to Soar on Roaring Kitty Rally (InvestorPlace) +16.32%
07:34AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
06:30AM 7 Stocks at High Risk of Bankruptcy: Is Your Portfolio Safe? (InvestorPlace)
Apr-27-24 06:00AM Bragar Eagel & Squire is Investigating Certain Officers and Directors of Talis, TaskUs, and RTR on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm (GlobeNewswire)
Apr-15-24 08:19AM What Rent the Runways 360% stock surge reveals about the future of AI in fashion (Fortune) -23.45%
Apr-12-24 12:45PM Rent the Runway Stock Surge Shows Investors Penchant for AI (Sourcing Journal)
08:30AM Rent the Runway, Inc. (NASDAQ:RENT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Apr-11-24 05:21PM 5 Investors Betting Big on Rent the Runway (RENT) Stock (InvestorPlace) +161.89%
MIGI - Mawson Infrastructure Group Inc - Stock Price Chart
TickerMIGI [NASD]
CompanyMawson Infrastructure Group Inc
CountryUSA
IndustryCapital Markets
Market Cap19.97MEPS (ttm)-4.24
P/E-EPS this Y49.74%
Forward P/E-EPS next Y-
PEG-EPS past 5Y36.15%
P/S0.37EPS next 5Y-
P/B1.46EPS Q/Q-49.23%
Dividend-Sales Q/Q144.72%
Insider Own15.22%Inst Own5.84%
Insider Trans0.00%Inst Trans-
Short Float3.38%EarningsMay 15/a
Analyst Recom1.00Target Price3.00
Avg Volume393.71K52W Range0.43 - 4.40
May-20-24 08:50AM Mawson Infrastructure Group Inc. Announces Monthly Operational Update for April 2024 (GlobeNewswire) +20.00%
May-15-24 11:52PM MIGI Stock Earnings: Mawson Infra Gr Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:15PM Mawson Infrastructure Group Inc. Reports Q1 2024 Financial Results (GlobeNewswire)
May-09-24 04:35PM Mawson Infrastructure Group Announces Hiring of Head of Corporate Strategy and Head of Corporate Development (GlobeNewswire)
May-07-24 10:00AM Gateway Group Announces Preliminary Presenting Companies for Gateway Conference in San Francisco on September 4-5, 2024 (GlobeNewswire) -12.31%
Apr-30-24 09:15AM Mawson Infrastructure Group Announces Expansion Plans at Midland, Pennsylvania Facilities (GlobeNewswire) -12.12%
Apr-18-24 07:00AM Mawson Infrastructure Group Inc. Announces Monthly Operational Update for March 2024 (GlobeNewswire) +11.00%
Apr-15-24 05:15PM Mawson Infrastructure Group Inc. Announces New Board Chair (GlobeNewswire) -8.00%
Apr-01-24 06:05AM Mawson Infrastructure Group Inc. Reports Q4 and Fiscal Year 2023 Financial Results (GlobeNewswire) -9.15%
Mar-27-24 08:50AM Mawson Infrastructure Group Expands Co-Location Business (GlobeNewswire) -5.30%
LSDI - Lucy Scientific Discovery Inc - Stock Price Chart
TickerLSDI [NASD]
CompanyLucy Scientific Discovery Inc
CountryCanada
IndustryDrug Manufacturers - Specialty & Generic
Market Cap2.22MEPS (ttm)-0.72
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S110.88EPS next 5Y-
P/B273.91EPS Q/Q-78.19%
Dividend-Sales Q/Q-
Insider Own36.91%Inst Own6.46%
Insider Trans0.00%Inst Trans-
Short Float3.33%Earnings-
Analyst Recom1.00Target Price14.00
Avg Volume1.20M52W Range0.44 - 12.80
May-16-24 12:08PM McDonald's $5 Meal Deal: What to Know About New Menu Special Coming in June (InvestorPlace) +211.76%
11:32AM Why Is Lucy Scientific Discovery (LSDI) Stock Up 227% Today? (InvestorPlace)
May-08-24 07:31AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) +5.26%
Feb-16-24 04:05PM Lucy Scientific Discovery Inc. Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement (Business Wire)
Oct-18-23 07:00AM Lucy Scientific Discovery's Alternative Mental Health Treatments to Provide Opportunity to Improve Mental Health (GlobeNewswire) +6.80%
Sep-26-23 08:30AM Lucy Scientific Discovery (NASDAQ: LSDI) Acquisitions Create Golden Opportunity for Growth, Success (GlobeNewswire) -7.07%
Sep-20-23 08:30AM Lucy Scientific Discovery (NASDAQ: LSDI) Leverages Power of M&A to Capitalize on Synergistic Growth (GlobeNewswire)
Sep-15-23 09:30AM Lucy Scientific Discovery Collaborates to Unlock the Value of Brands Through Strategic Acquisitions (NewMediaWire)
08:30AM Lucy Scientific Discovery Announces Acquisition of BlueSky Wellness (NewMediaWire)
Sep-13-23 01:37AM Lucy Scientific Discovery to Acquire BlueSky Wellness in All-Stock Transaction (NewMediaWire) -9.31%
CMAX - CareMax Inc - Stock Price Chart
TickerCMAX [NASD, RUT]
CompanyCareMax Inc
CountryUSA
IndustryHealth Information Services
Market Cap12.96MEPS (ttm)-172.31
P/E-EPS this Y85.17%
Forward P/E-EPS next Y41.96%
PEG-EPS past 5Y-
P/S0.02EPS next 5Y-
P/B0.64EPS Q/Q-1458.51%
Dividend-Sales Q/Q34.26%
Insider Own38.16%Inst Own44.75%
Insider Trans0.00%Inst Trans-13.09%
Short Float10.14%EarningsMay 09/a
Analyst Recom3.00Target Price4.80
Avg Volume76.04K52W Range2.23 - 126.00
May-09-24 11:52PM CMAX Stock Earnings: CareMax Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace) -9.34%
05:09PM CareMax Reports First Quarter 2024 Results (Business Wire)
Mar-18-24 02:52PM CMAX Stock Earnings: CareMax Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace) -23.47%
06:55AM CareMax Reports Fourth Quarter and Full Year 2023 Results (Business Wire)
Jan-29-24 05:00PM CareMax Announces 1-for-30 Reverse Stock Split (Business Wire)
Nov-12-23 12:01PM CareMax, Inc. (NASDAQ:CMAX) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 08:04AM CareMax Inc (CMAX) Reports Growth Amidst Challenges in Q3 2023 (GuruFocus.com) -14.08%
06:55AM CareMax Reports Third Quarter 2023 Results (Business Wire)
Oct-25-23 06:55AM CareMax Schedules Third Quarter 2023 Earnings Conference Call (Business Wire) -6.22%
Sep-06-23 06:55AM CareMax to Present at the Morgan Stanley 21st Annual Global Healthcare Conference (Business Wire) -5.38%
12345678910⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.